1. Academic Validation
  2. Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance Through p53 Acetylation

Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance Through p53 Acetylation

  • Adv Sci (Weinh). 2023 Dec 12:e2305620. doi: 10.1002/advs.202305620.
Huan Li 1 Chao Song 1 Yang Zhang 1 Guohao Liu 2 Hailong Mi 1 Yachao Li 1 Zhiye Chen 2 Xiaoyu Ma 2 Po Zhang 2 Lidong Cheng 2 Peng Peng 2 Hongtao Zhu 2 Zirong Chen 2 Minhai Dong 2 Sui Chen 2 Hao Meng 3 QunGen Xiao 2 Honglian Li 1 Qiulian Wu 4 Baofeng Wang 2 Suojun Zhang 2 Kai Shu 2 Feng Wan 2 Dongsheng Guo 2 Wenchao Zhou 3 Lin Zhou 1 Feng Mao 2 Jeremy N Rich 4 5 Xingjiang Yu 1
Affiliations

Affiliations

  • 1 Department of Histology and Embryology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • 2 Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • 3 Intelligent Pathology Institute, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230031, China.
  • 4 UPMC Hillman Cancer Center, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, 15219, USA.
  • 5 Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
Abstract

Glioblastoma (GBM) is a lethal Cancer characterized by hypervascularity and necrosis associated with hypoxia. Here, it is found that hypoxia preferentially induces the actin-binding protein, Transgelin (TAGLN), in GBM stem cells (GSCs). Mechanistically, TAGLN regulates HIF1α transcription and stabilizes HDAC2 to deacetylate p53 and maintain GSC self-renewal. To translate these findings into preclinical therapeutic paradigm, it is found that sodium valproate (VPA) is a specific inhibitor of TAGLN/HDAC2 function, with augmented efficacy when combined with natural borneol (NB) in vivo. Thus, TAGLN promotes Cancer stem cell survival in hypoxia and informs a novel therapeutic paradigm.

Keywords

HDAC2; HIF1α Hypoxia; glioblastoma stem cells; natural borneol; sodium valproate; transgelin.

Figures
Products